Search by Drug Name or NDC

    NDC 51759-0850-11 UZEDY 200 mg/.56mL Details

    UZEDY 200 mg/.56mL

    UZEDY is a SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is RISPERIDONE.

    Product Information

    NDC 51759-0850
    Product ID 51759-850_a0b81ec6-78d0-4be1-8cad-135a94cf403c
    Associated GPIs
    GCN Sequence Number 084733
    GCN Sequence Number Description risperidone SUSER SYR 200MG/0.56 SUBCUT
    HIC3 H7T
    HIC3 Description ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
    GCN 54106
    HICL Sequence Number 008721
    HICL Sequence Number Description RISPERIDONE
    Brand/Generic Brand
    Proprietary Name UZEDY
    Proprietary Name Suffix n/a
    Non-Proprietary Name risperidone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SUSPENSION, EXTENDED RELEASE
    Route SUBCUTANEOUS
    Active Ingredient Strength 200
    Active Ingredient Units mg/.56mL
    Substance Name RISPERIDONE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA213586
    Listing Certified Through 2024-12-31

    Package

    NDC 51759-0850-11 (51759085011)

    NDC Package Code 51759-850-11
    Billing NDC 51759085011
    Package 1 SYRINGE, GLASS in 1 CARTON (51759-850-11) / .56 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2023-05-01
    NDC Exclude Flag N
    Pricing Information N/A